Modera Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
50,928
-756
-1% -$19.8K 0.01% 313
2026
Q1
$1.45M Sell
51,684
-12,532
-20% -$334K 0.02% 291
2025
Q4
$1.6M Buy
64,216
+3,876
+6% +$97.7K 0.02% 285
2025
Q3
$1.54M Sell
60,340
-1,753
-3% -$43.3K 0.02% 287
2025
Q2
$1.51M Sell
62,093
-4,757
-7% -$111K 0.02% 288
2025
Q1
$1.69M Buy
66,850
+4,414
+7% +$116K 0.02% 261
2024
Q4
$1.66M Sell
62,436
-363
-0.6% -$9.85K 0.02% 266
2024
Q3
$1.82M Buy
62,799
+50
+0.1% +$1.46K 0.02% 242
2024
Q2
$1.76M Sell
62,749
-29,005
-32% -$799K 0.03% 238
2024
Q1
$2.55M Sell
91,754
-5,315
-5% -$147K 0.04% 206
2023
Q4
$2.79M Sell
97,069
-23,480
-19% -$710K 0.05% 197
2023
Q3
$4M Sell
120,549
-6,622
-5% -$234K 0.08% 166
2023
Q2
$4.66M Buy
127,171
+52,600
+71% +$2.05M 0.08% 158
2023
Q1
$3.04M Buy
74,571
+172
+0.2% +$7.43K 0.12% 76
2022
Q4
$3.81M Buy
74,399
+1,166
+2% +$55.9K 0.16% 68
2022
Q3
$3.21M Sell
73,233
-1,105
-1% -$53.7K 0.16% 68
2022
Q2
$3.9M Buy
74,338
+81
+0.1% +$4.13K 0.19% 66
2022
Q1
$3.84M Buy
74,257
+3,314
+5% +$172K 0.17% 70
2021
Q4
$4.19M Buy
70,943
+979
+1% +$48.5K 0.16% 68
2021
Q3
$3.01M Buy
69,964
+4,616
+7% +$204K 0.15% 58
2021
Q2
$2.56M Buy
65,348
+760
+1% +$29.6K 0.14% 61
2021
Q1
$2.34M Sell
64,588
-2,889
-4% -$103K 0.15% 58
2020
Q4
$2.48M Buy
67,477
+40,076
+146% +$1.47M 0.2% 51
2020
Q3
$954K Sell
27,401
-2,791
-9% -$97.9K 0.14% 59
2020
Q2
$937K Sell
30,192
-1,649
-5% -$56K 0.15% 56
2020
Q1
$986K Buy
31,841
+447
+1% +$15.2K 0.21% 53
2019
Q4
$1.17M Sell
31,394
-527
-2% -$18.8K 0.18% 45
2019
Q3
$1.09M Sell
31,921
-420
-1% -$15.3K 0.18% 47
2019
Q2
$1.33M Buy
32,341
+2,431
+8% +$96.5K 0.24% 38
2019
Q1
$1.21M Buy
29,910
+2,525
+9% +$101K 0.23% 41
2018
Q4
$1.13M Sell
27,385
-1,279
-4% -$53.1K 0.22% 40
2018
Q3
$1.2M Sell
28,664
-556
-2% -$21.4K 0.24% 39
2018
Q2
$1.01M Buy
29,220
+1,345
+5% +$46K 0.21% 44
2018
Q1
$939K Buy
27,875
+1,778
+7% +$61.1K 0.19% 43
2017
Q4
$897K Buy
26,097
+874
+3% +$29.8K 0.19% 46
2017
Q3
$854K Sell
25,223
-1,810
-7% -$58.2K 0.19% 44
2017
Q2
$862K Sell
27,033
-2,121
-7% -$66.9K 0.21% 42
2017
Q1
$946K Buy
29,154
+5,922
+25% +$187K 0.24% 42
2016
Q4
$716K Buy
23,232
+147
+0.6% +$4.49K 0.24% 46
2016
Q3
$742K Buy
23,085
+383
+2% +$12.8K 0.25% 44
2016
Q2
$758K Buy
22,702
+5,364
+31% +$171K 0.27% 40
2016
Q1
$488K Buy
17,338
+6,961
+67% +$199K 0.17% 58
2015
Q4
$318K Sell
10,377
-448
-4% -$14.1K 0.13% 56
2015
Q3
$323K Buy
10,825
+1,838
+20% +$58.9K 0.13% 54
2015
Q2
$286K Sell
8,987
-837
-9% -$27.3K 0.11% 60
2015
Q1
$314K Buy
9,824
+1,532
+18% +$48.7K 0.12% 59
2014
Q4
$245K Sell
8,292
-943
-10% -$27K 0.1% 72
2014
Q3
$259K Buy
9,235
+1,270
+16% +$35.6K 0.11% 69
2014
Q2
$224K Buy
7,965
+88
+1% +$2.51K 0.1% 57
2014
Q1
$240K Sell
7,877
-1,356
-15% -$40.4K 0.1% 53
2013
Q4
$268K Buy
9,233
+1,137
+14% +$33.1K 0.1% 73
2013
Q3
$221K Sell
8,096
-82
-1% -$2.23K 0.11% 51
2013
Q2
$217K Buy
+8,178
New +$226K 0.11% 49

Other funds holding PFE

Modera Wealth Management's PFE Position: Q2 2026 in Review

Modera Wealth Management reduced its Pfizer (PFE) stake by 1.5% in Q2 2026, selling an estimated $19.8K and leaving 50,928 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #313.

Modera Wealth Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.66M in Q2 2023. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Modera Wealth Management held 50,928 shares of Pfizer worth $1.23M as of Q2 2026.
  • Modera Wealth Management sold 756 Pfizer shares in Q2 2026, an estimated $19.8K.
  • Pfizer made up 0.01% of Modera Wealth Management's portfolio in Q2 2026, its #313 holding.
  • Modera Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Modera Wealth Management's Pfizer position peaked at $4.66M in Q2 2023.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Modera Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.